pfe
PFE22.280USD
-0.689-3.00%
종가 05/09, 16:00（ET）시세는 15분 지연됩니다
126.66B시가총액
15.77P/E TTM
자세한 내용은 Pfizer Inc 회사
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
회사 정보
회사 코드PFE
회사 이름Pfizer Inc
상장일Jan 17, 1944
설립일1942
CEODr. Albert Bourla, Ph.D.
직원 수81000
유형Ordinary Share
회계 연도 종료Jan 17
주소66 Hudson Boulevard East
도시NEW YORK
증권 거래소NYSE Consolidated
국가United States of America
우편 번호10001-2192
전화12127332323
웹사이트https://www.pfizer.com/
회사 코드PFE
상장일Jan 17, 1944
설립일1942
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Albert Bourla, Ph.D.
Dr. Albert Bourla, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
372.89K
+10.54%
Mr. Douglas M. Lankler
Mr. Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
161.04K
+8.26%
Ms. Sally Susman
Ms. Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Executive Vice President, Chief Corporate Affairs Officer
95.94K
+8.23%
Mr. Michael (Ike) Mcdermott
Mr. Michael (Ike) Mcdermott
Executive Vice President, Chief Global Supply Officer
Executive Vice President, Chief Global Supply Officer
70.77K
-0.78%
Mr. Ronald E. Blaylock
Mr. Ronald E. Blaylock
Independent Director
Independent Director
32.46K
+149.67%
Ms. Lidia L. Fonseca, Ph.D.
Ms. Lidia L. Fonseca, Ph.D.
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
30.96K
--
Mr. Aamir Malik
Mr. Aamir Malik
Executive Vice President, Chief US Commercial Officer
Executive Vice President, Chief US Commercial Officer
29.55K
+7.80K%
Ms. Payal Sahni
Ms. Payal Sahni
Executive Vice President, Chief People Experience Officer
Executive Vice President, Chief People Experience Officer
24.85K
+6.62%
Mr. Cyrus Taraporevala
Mr. Cyrus Taraporevala
Independent Director
Independent Director
10.00K
--
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
10.00K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Albert Bourla, Ph.D.
Dr. Albert Bourla, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
372.89K
+10.54%
Mr. Douglas M. Lankler
Mr. Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
161.04K
+8.26%
Ms. Sally Susman
Ms. Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Executive Vice President, Chief Corporate Affairs Officer
95.94K
+8.23%
Mr. Michael (Ike) Mcdermott
Mr. Michael (Ike) Mcdermott
Executive Vice President, Chief Global Supply Officer
Executive Vice President, Chief Global Supply Officer
70.77K
-0.78%
Mr. Ronald E. Blaylock
Mr. Ronald E. Blaylock
Independent Director
Independent Director
32.46K
+149.67%
Ms. Lidia L. Fonseca, Ph.D.
Ms. Lidia L. Fonseca, Ph.D.
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
30.96K
--
수익 분석
통화: USD업데이트 시간: Sun, Apr 6
통화: USD업데이트 시간: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Eliquis alliance revenues and direct sales
7.37B
11.58%
Prevnar family
6.41B
10.08%
Paxlovid
5.72B
8.98%
Vyndaqel family
5.45B
8.57%
Comirnaty
5.35B
8.41%
Other
33.33B
52.38%
지역별USD
이름
수익
비율
United States
38.69B
60.81%
Developed Markets
16.06B
25.24%
Emerging Markets
8.88B
13.95%
사업별
지역별
사업별USD
이름
수익
비율
Eliquis alliance revenues and direct sales
7.37B
11.58%
Prevnar family
6.41B
10.08%
Paxlovid
5.72B
8.98%
Vyndaqel family
5.45B
8.57%
Comirnaty
5.35B
8.41%
Other
33.33B
52.38%
주주
업데이트 시간: Fri, Feb 21
업데이트 시간: Fri, Feb 21
주주 통계
유형
주주 통계
주주
비율
The Vanguard Group, Inc.
9.16%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Global Advisors (US)
5.11%
Wellington Management Company, LLP
2.46%
Geode Capital Management, L.L.C.
2.12%
Other
76.02%
주주 통계
주주
비율
The Vanguard Group, Inc.
9.16%
BlackRock Institutional Trust Company, N.A.
5.13%
State Street Global Advisors (US)
5.11%
Wellington Management Company, LLP
2.46%
Geode Capital Management, L.L.C.
2.12%
Other
76.02%
유형
주주
비율
Investment Advisor/Hedge Fund
31.19%
Investment Advisor
24.08%
Research Firm
3.04%
Pension Fund
2.22%
Bank and Trust
1.83%
Hedge Fund
1.73%
Sovereign Wealth Fund
1.64%
Insurance Company
1.19%
Holding Company
0.04%
Other
33.04%
기관 주식 보유
업데이트 시간: Fri, Feb 21
업데이트 시간: Fri, Feb 21
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
5011
3.92B
68.87%
-38.00M
2024Q4
5153
3.84B
67.74%
-83.26M
2024Q3
5005
3.85B
67.99%
-51.77M
2024Q2
5026
3.84B
67.75%
-120.77M
2024Q1
5032
3.89B
68.71%
-120.39M
2023Q4
5089
3.97B
70.25%
-96.67M
2023Q3
4952
4.00B
70.89%
-71.80M
2023Q2
4962
4.02B
71.16%
-62.35M
2023Q1
4947
4.02B
71.28%
-30.98M
2022Q4
4927
4.01B
71.39%
-30.90M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
515.98M
9.1%
+2.34M
+0.46%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
279.54M
4.93%
+4.29M
+1.56%
Dec 31, 2024
State Street Global Advisors (US)
290.48M
5.12%
+23.75K
+0.01%
Dec 31, 2024
Wellington Management Company, LLP
139.99M
2.47%
-23.74M
-14.50%
Dec 31, 2024
Geode Capital Management, L.L.C.
120.59M
2.13%
+2.92M
+2.48%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
87.79M
1.55%
+3.82M
+4.55%
Dec 31, 2024
MFS Investment Management
74.22M
1.31%
+5.45M
+7.92%
Dec 31, 2024
State Farm Insurance Companies
54.51M
0.96%
--
--
Dec 31, 2024
BlackRock Asset Management Ireland Limited
45.96M
0.81%
+2.00M
+4.55%
Dec 31, 2024
Charles Schwab Investment Management, Inc.
155.46M
2.74%
+25.32M
+19.45%
Dec 31, 2024
더 보기
관련 ETF
업데이트 시간: Tue, May 6
업데이트 시간: Tue, May 6
이름
비율
First Trust NASDAQ Pharmaceuticals ETF
7.83%
First Trust Morningstar Dividend Leaders Index Fund
7.59%
Parnassus Value Select ETF
5.89%
NYLI Healthy Hearts ETF
4.77%
WBI BullBear Yield 3000 ETF
4.75%
Invesco Pharmaceuticals ETF
4.72%
Vaneck Durable High Dividend ETF
4.65%
VanEck Pharmaceutical ETF
4.65%
Amplify Weight Loss Drug & Treatment ETF
4.36%
VanEck Morningstar Wide Moat Value ETF
4.36%
더 보기
First Trust NASDAQ Pharmaceuticals ETF
비율7.83%
First Trust Morningstar Dividend Leaders Index Fund
비율7.59%
Parnassus Value Select ETF
비율5.89%
NYLI Healthy Hearts ETF
비율4.77%
WBI BullBear Yield 3000 ETF
비율4.75%
Invesco Pharmaceuticals ETF
비율4.72%
Vaneck Durable High Dividend ETF
비율4.65%
VanEck Pharmaceutical ETF
비율4.65%
Amplify Weight Loss Drug & Treatment ETF
비율4.36%
VanEck Morningstar Wide Moat Value ETF
비율4.36%
주식 배당금
지난 5년 동안 총
44.91B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Dec 12, 2024
PFE.NB Interim Cash Dividend of gross USD 0.43 paid on Mar 07, 2025 going ex on Jan 24, 2025
Jan 24, 2025
Mar 07, 2025
Jan 24, 2025
Oct 09, 2024
PFE.NB Final Cash Dividend of gross USD 0.42 paid on Dec 02, 2024 going ex on Nov 08, 2024
Nov 08, 2024
Dec 02, 2024
Nov 08, 2024
Jun 26, 2024
PFE.NB Interim Cash Dividend of gross USD 0.42 paid on Sep 03, 2024 going ex on Jul 26, 2024
Jul 26, 2024
Sep 03, 2024
Jul 26, 2024
Apr 24, 2024
PFE.NB Interim Cash Dividend of gross USD 0.42 paid on Jun 14, 2024 going ex on May 09, 2024
May 10, 2024
Jun 14, 2024
May 09, 2024
Dec 14, 2023
PFE.NB Interim Cash Dividend of gross USD 0.42 paid on Mar 01, 2024 going ex on Jan 25, 2024
Jan 26, 2024
Mar 01, 2024
Jan 25, 2024
Oct 04, 2023
PFE.NB Final Cash Dividend of gross USD 0.41 paid on Dec 04, 2023 going ex on Nov 09, 2023
Nov 10, 2023
Dec 04, 2023
Nov 09, 2023
Jun 22, 2023
PFE.NB Interim Cash Dividend of gross USD 0.41 paid on Sep 05, 2023 going ex on Jul 27, 2023
Jul 28, 2023
Sep 05, 2023
Jul 27, 2023
Apr 26, 2023
PFE.NB Interim Cash Dividend of gross USD 0.41 paid on Jun 09, 2023 going ex on May 11, 2023
May 12, 2023
Jun 09, 2023
May 11, 2023
Dec 09, 2022
PFE.NB Interim Cash Dividend of gross USD 0.41 paid on Mar 03, 2023 going ex on Jan 26, 2023
Jan 27, 2023
Mar 03, 2023
Jan 26, 2023
Sep 22, 2022
PFE.NB Final Cash Dividend of gross USD 0.4 paid on Dec 05, 2022 going ex on Nov 03, 2022
Nov 04, 2022
Dec 05, 2022
Nov 03, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음